252 related articles for article (PubMed ID: 27651465)
1. Validating genetic markers of response to recombinant human growth hormone in children with growth hormone deficiency and Turner syndrome: the PREDICT validation study.
Stevens A; Murray P; Wojcik J; Raelson J; Koledova E; Chatelain P; Clayton P;
Eur J Endocrinol; 2016 Dec; 175(6):633-643. PubMed ID: 27651465
[TBL] [Abstract][Full Text] [Related]
2. A pharmacogenomic approach to the treatment of children with GH deficiency or Turner syndrome.
Clayton P; Chatelain P; Tatò L; Yoo HW; Ambler GR; Belgorosky A; Quinteiro S; Deal C; Stevens A; Raelson J; Croteau P; Destenaves B; Olivier C
Eur J Endocrinol; 2013 Sep; 169(3):277-89. PubMed ID: 23761422
[TBL] [Abstract][Full Text] [Related]
3. GHR and VDR genes do not contribute to the growth hormone (GH) response in GH deficient and Turner syndrome patients.
Alvarez-Nava F; Marcano H; Pardo T; Paoli M; Gunczler P; Soto M; Villaloboss J; Lanes R
J Pediatr Endocrinol Metab; 2010 Aug; 23(8):773-82. PubMed ID: 21073120
[TBL] [Abstract][Full Text] [Related]
4. Adherence to treatment in children with growth hormone deficiency, small for gestational age and Turner syndrome in Mexico: results of the Easypod™ connect observational study (ECOS).
Blanco-López A; Antillón-Ferreira C; Saavedra-Castillo E; Barrientos-Pérez M; Rivero-Escalante H; Flores-Caloca O; Calzada-León R; Rosas-Guerra CC; Koledova E; Chiquete E; Ayala-Estrada A
J Endocrinol Invest; 2020 Oct; 43(10):1447-1452. PubMed ID: 32239476
[TBL] [Abstract][Full Text] [Related]
5. Effect of growth hormone treatment on children with idiopathic short stature (ISS), idiopathic growth hormone deficiency (IGHD), small for gestational age (SGA) and Turner syndrome (TS) in a tertiary care center.
Al Shaikh A; Daftardar H; Alghamdi AA; Jamjoom M; Awidah S; Ahmed ME; Soliman AT
Acta Biomed; 2020 Mar; 91(1):29-40. PubMed ID: 32191651
[TBL] [Abstract][Full Text] [Related]
6. Genetic predictors of long-term response to growth hormone (GH) therapy in children with GH deficiency and Turner syndrome: the influence of a SOCS2 polymorphism.
Braz AF; Costalonga EF; Trarbach EB; Scalco RC; Malaquias AC; Guerra-Junior G; Antonini SR; Mendonca BB; Arnhold IJ; Jorge AA
J Clin Endocrinol Metab; 2014 Sep; 99(9):E1808-13. PubMed ID: 24905066
[TBL] [Abstract][Full Text] [Related]
7. Real-life GH dosing patterns in children with GHD, TS or born SGA: a report from the NordiNet® International Outcome Study.
Blankenstein O; Snajderova M; Blair J; Pournara E; Pedersen BT; Petit IO
Eur J Endocrinol; 2017 Aug; 177(2):145-155. PubMed ID: 28522645
[TBL] [Abstract][Full Text] [Related]
8. GH deficiency status combined with GH receptor polymorphism affects response to GH in children.
Valsesia A; Chatelain P; Stevens A; Peterkova VA; Belgorosky A; Maghnie M; Antoniazzi F; Koledova E; Wojcik J; Farmer P; Destenaves B; Clayton P;
Eur J Endocrinol; 2015 Dec; 173(6):777-89. PubMed ID: 26340968
[TBL] [Abstract][Full Text] [Related]
9. Gene expression signatures predict response to therapy with growth hormone.
Stevens A; Murray P; De Leonibus C; Garner T; Koledova E; Ambler G; Kapelari K; Binder G; Maghnie M; Zucchini S; Bashnina E; Skorodok J; Yeste D; Belgorosky A; Siguero JL; Coutant R; Vangsøy-Hansen E; Hagenäs L; Dahlgren J; Deal C; Chatelain P; Clayton P
Pharmacogenomics J; 2021 Oct; 21(5):594-607. PubMed ID: 34045667
[TBL] [Abstract][Full Text] [Related]
10. Effect of growth hormone therapy on Taiwanese children with growth hormone deficiency.
Huang YH; Wai YY; Van YH; Lo FS
J Formos Med Assoc; 2012 Jul; 111(7):355-63. PubMed ID: 22817812
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the GeNeSIS clinical study.
Cappa M; Iughetti L; Loche S; Maghnie M; Vottero A;
J Endocrinol Invest; 2016 Jun; 39(6):667-77. PubMed ID: 27223400
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomics of insulin-like growth factor-I generation during GH treatment in children with GH deficiency or Turner syndrome.
Stevens A; Clayton P; Tatò L; Yoo HW; Rodriguez-Arnao MD; Skorodok J; Ambler GR; Zignani M; Zieschang J; Della Corte G; Destenaves B; Champigneulle A; Raelson J; Chatelain P
Pharmacogenomics J; 2014 Feb; 14(1):54-62. PubMed ID: 23567489
[TBL] [Abstract][Full Text] [Related]
13. Needle-Free and Needle-Based Growth Hormone Therapy in Children: A Pooled Analysis of Three Long-Term Observational Studies.
Rohrer TR; Ceplis-Kastner S; Jorch N; Müller HL; Pfäffle R; Reinehr T; Richter-Unruh A; Weißenbacher C; Holterhus PM; Ferring Arzneimittel GmbH DSC
Horm Res Paediatr; 2018; 90(6):393-406. PubMed ID: 30836359
[TBL] [Abstract][Full Text] [Related]
14. The exon 3-deleted/full-length growth hormone receptor polymorphism and response to growth hormone therapy in growth hormone deficiency and Turner syndrome: a multicenter study.
Baş F; Darendeliler F; Aycan Z; Çetinkaya E; Berberoğlu M; Sıklar Z; Öcal G; Timirci Ö; Çetinkaya S; Darcan Ş; Gökşen Şimşek D; Bideci A; Cinaz P; Böber E; Demir K; Bereket A; Turan S; Atabek ME; Tütüncüler F; Isbir T; Bozkurt N; Kabataş Eryılmaz S; Uzunhan O; Küçükemre Aydın B; Bundak R
Horm Res Paediatr; 2012; 77(2):85-93. PubMed ID: 22456308
[TBL] [Abstract][Full Text] [Related]
15. The interactive effect of GHR-exon 3 and -202 A/C IGFBP3 polymorphisms on rhGH responsiveness and treatment outcomes in patients with Turner syndrome.
Braz AF; Costalonga EF; Montenegro LR; Trarbach EB; Antonini SR; Malaquias AC; Ramos ES; Mendonca BB; Arnhold IJ; Jorge AA
J Clin Endocrinol Metab; 2012 Apr; 97(4):E671-7. PubMed ID: 22278433
[TBL] [Abstract][Full Text] [Related]
16. Accurate long-term prediction of height during the first four years of growth hormone treatment in prepubertal children with growth hormone deficiency or Turner Syndrome.
Ranke MB; Lindberg A; Brosz M; Kaspers S; Loftus J; Wollmann H; Kołtowska-Haggstrom M; Roelants M
Horm Res Paediatr; 2012; 78(1):8-17. PubMed ID: 22832697
[TBL] [Abstract][Full Text] [Related]
17. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA
Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781
[TBL] [Abstract][Full Text] [Related]
18. Genetic Polymorphisms as Predictive Markers of Response to Growth Hormone Therapy in Children with Growth Hormone Deficiency.
Jung AM; Zenker M; Lißewski C; Schanze D; Wagenpfeil S; Rohrer TR
Klin Padiatr; 2017 Sep; 229(5):267-273. PubMed ID: 28806841
[No Abstract] [Full Text] [Related]
19. The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children.
Binder G; Baur F; Schweizer R; Ranke MB
J Clin Endocrinol Metab; 2006 Feb; 91(2):659-64. PubMed ID: 16291706
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and growth hormone (GH) therapy in children with GH deficiency: experience in King Chulalongkorn Memorial Hospital, Thailand.
Wacharasindhu S; Supornsilchai V; Aroonparkmongkol S; Srivuthana S
J Med Assoc Thai; 2007 Oct; 90(10):2047-52. PubMed ID: 18041422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
